These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7996140)

  • 41. A protective immune response in mice to viral components other than hemagglutinin in a live influenza A virus vaccine model.
    Horimoto T; Takada A; Iwatsuki-Horimoto K; Kawaoka Y
    Vaccine; 2004 Jun; 22(17-18):2244-7. PubMed ID: 15149783
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reduced levels of neuraminidase of influenza A viruses correlate with attenuated phenotypes in mice.
    Solorzano A; Zheng H; Fodor E; Brownlee GG; Palese P; García-Sastre A
    J Gen Virol; 2000 Mar; 81(Pt 3):737-42. PubMed ID: 10675411
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cross-protection against influenza virus infection afforded by trivalent inactivated vaccines inoculated intranasally with cholera toxin B subunit.
    Tamura S; Ito Y; Asanuma H; Hirabayashi Y; Suzuki Y; Nagamine T; Aizawa C; Kurata T
    J Immunol; 1992 Aug; 149(3):981-8. PubMed ID: 1634780
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy and duration of immunity of a combined equine influenza and equine herpesvirus vaccine against challenge with an American-like equine influenza virus (A/equi-2/Kentucky/95).
    Heldens JG; Pouwels HG; van Loon AA
    Vet J; 2004 Mar; 167(2):150-7. PubMed ID: 14975389
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunization with recombinant modified vaccinia Ankara (rMVA) constructs encoding the HA or NP gene protects ponies from equine influenza virus challenge.
    Breathnach CC; Clark HJ; Clark RC; Olsen CW; Townsend HG; Lunn DP
    Vaccine; 2006 Feb; 24(8):1180-90. PubMed ID: 16194586
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunization with baculovirus displayed H6 hemagglutinin vaccine protects mice against lethal H6 influenza virus challenge.
    Musthaq SK; Kumar SR; Szyporta M; Kwang J
    Antiviral Res; 2014 Sep; 109():42-53. PubMed ID: 24973759
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Requirements for DI particle prophylaxis against vesicular stomatitis virus infection in vivo.
    Jones CL; Holland JJ
    J Gen Virol; 1980 Jul; 49(1):215-20. PubMed ID: 6252288
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of influenza A H3N8 virus infections in mice by morpholino oligomers.
    Lupfer C; Stein DA; Mourich DV; Tepper SE; Iversen PL; Pastey M
    Arch Virol; 2008; 153(5):929-37. PubMed ID: 18369525
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A novel broad-spectrum treatment for respiratory virus infections: influenza-based defective interfering virus provides protection against pneumovirus infection in vivo.
    Easton AJ; Scott PD; Edworthy NL; Meng B; Marriott AC; Dimmock NJ
    Vaccine; 2011 Mar; 29(15):2777-84. PubMed ID: 21320545
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Defective interfering influenza virus RNAs: time to reevaluate their clinical potential as broad-spectrum antivirals?
    Dimmock NJ; Easton AJ
    J Virol; 2014 May; 88(10):5217-27. PubMed ID: 24574404
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Persistence of virulent Semliki Forest virus in mouse brain following co-inoculation with defective interfering particles.
    Atkinson T; Barrett AD; Mackenzie A; Dimmock NJ
    J Gen Virol; 1986 Jun; 67 ( Pt 6)():1189-94. PubMed ID: 3011976
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Protection against lethal influenza virus challenge by RNA interference in vivo.
    Tompkins SM; Lo CY; Tumpey TM; Epstein SL
    Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8682-6. PubMed ID: 15173583
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Properties of influenza virus isolated from the bodies of mice at different stages of experimental influenza].
    Frolov AF; Shcherbinskaia AM; Sklianskaia EI
    Vopr Virusol; 1981; (5):544-7. PubMed ID: 7336682
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influenza Defective Interfering Virus Promotes Multiciliated Cell Differentiation and Reduces the Inflammatory Response in Mice.
    Wang C; Honce R; Salvatore M; Chow D; Randazzo D; Yang J; Twells NM; Mahal LK; Schultz-Cherry S; Ghedin E
    J Virol; 2023 Jun; 97(6):e0049323. PubMed ID: 37255439
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Defective segment 1 RNAs that interfere with production of infectious influenza A virus require at least 150 nucleotides of 5' sequence: evidence from a plasmid-driven system.
    Duhaut SD; Dimmock NJ
    J Gen Virol; 2002 Feb; 83(Pt 2):403-411. PubMed ID: 11807233
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cloned Defective Interfering Influenza RNA and a Possible Pan-Specific Treatment of Respiratory Virus Diseases.
    Dimmock NJ; Easton AJ
    Viruses; 2015 Jul; 7(7):3768-88. PubMed ID: 26184282
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Defective interfering viruses and their potential as antiviral agents.
    Marriott AC; Dimmock NJ
    Rev Med Virol; 2010 Jan; 20(1):51-62. PubMed ID: 20041441
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Preventive effect of UV-inactivated defective interfering influenza virus in experimental infection].
    Kantorovich-Prokudina EN; Kaverin NV; Semenova NP; Miasnikova IA; Berezina ON
    Vopr Virusol; 1978; (6):673-7. PubMed ID: 749346
    [No Abstract]   [Full Text] [Related]  

  • 59. Defective influenza viral ribonucleoproteins cause interference.
    Janda JM; Nayak DP
    J Virol; 1979 Nov; 32(2):697-702. PubMed ID: 501805
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modulation of Semliki Forest virus-induced infection of mice by defective-interfering virus.
    Barrett AD; Dimmock NJ
    J Infect Dis; 1984 Jul; 150(1):98-104. PubMed ID: 6086774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.